Cabaletta Bio (CABA) Net Equity Issued and Repurchased (2019 - 2025)

Cabaletta Bio's Net Equity Issued and Repurchased history runs 7 years deep, the most recent figure standing at -$25000.0 for Q3 2025.

• In Q3 2025, Net Equity Issued and Repurchased changed N/A year-over-year to -$25000.0; the TTM figure through Dec 2025 stood at $93.6 million (changed N/A YoY), while the FY2025 annual figure was $93.6 million, changed N/A from the prior year.
• Net Equity Issued and Repurchased for Q3 2025 stood at -$25000.0, down from $93.6 million in the prior quarter.
• The five-year high for Net Equity Issued and Repurchased was $93.8 million in Q2 2023, with the low at -$5.7 million in Q2 2024.
• The 5-year median for Net Equity Issued and Repurchased is $5.7 million (2024), against an average of $20.5 million.
• The sharpest annual moves came in 2021 and 2024: Net Equity Issued and Repurchased surged 1354400.0% in 2021, then tumbled 106.12% in 2024.
• Cabaletta Bio's Net Equity Issued and Repurchased stood at $13.5 million in 2021, then jumped by 142.6% to $32.9 million in 2022, then sank by 105.24% to -$1.7 million in 2023, then tumbled by 233.49% to -$5.7 million in 2024, then soared by 99.56% to -$25000.0 in 2025.
• Business Quant data shows CABA's Net Equity Issued and Repurchased at -$25000.0 in Q3 2025, $93.6 million in Q2 2025, and -$5.7 million in Q2 2024.